Literature DB >> 27305922

Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.

Tatiana M Kazdoba1, Prescott T Leach1, Mu Yang1, Jill L Silverman1, Marjorie Solomon1, Jacqueline N Crawley2.   

Abstract

Animal models provide preclinical tools to investigate the causal role of genetic mutations and environmental factors in the etiology of autism spectrum disorder (ASD). Knockout and humanized knock-in mice, and more recently knockout rats, have been generated for many of the de novo single gene mutations and copy number variants (CNVs) detected in ASD and comorbid neurodevelopmental disorders. Mouse models incorporating genetic and environmental manipulations have been employed for preclinical testing of hypothesis-driven pharmacological targets, to begin to develop treatments for the diagnostic and associated symptoms of autism. In this review, we summarize rodent behavioral assays relevant to the core features of autism, preclinical and clinical evaluations of pharmacological interventions, and strategies to improve the translational value of rodent models of autism.

Entities:  

Keywords:  Autism; Clinical trials; Cognition; Construct validity; Face validity; Genes; Mice; Mouse; Mutant models; Pharmacological treatment; Preclinical; Predictive validity; Rats; Repetitive behavior; Sociability; Social behavior; Translational; Ultrasonic vocalization

Mesh:

Year:  2016        PMID: 27305922      PMCID: PMC5116923          DOI: 10.1007/7854_2015_5003

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  357 in total

1.  Mildly impaired water maze performance in male Fmr1 knockout mice.

Authors:  R D'Hooge; G Nagels; F Franck; C E Bakker; E Reyniers; K Storm; R F Kooy; B A Oostra; P J Willems; P P De Deyn
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

2.  Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Authors:  Adelaide S Robb; Candace Andersson; Elizabeth E Bellocchio; George Manos; Carlos Rojas-Fernandez; Suja Mathew; Ronald Marcus; Randall Owen; Raymond Mankoski
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder.

Authors:  Craig A Erickson; Logan K Wink; Maureen C Early; Elizabeth Stiegelmeyer; Lauren Mathieu-Frasier; Vanessa Patrick; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2014-04

Review 4.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

5.  A pilot study of D-cycloserine in subjects with autistic disorder.

Authors:  David J Posey; Deborah L Kem; Naomi B Swiezy; Thayne L Sweeten; Ryan E Wiegand; Christopher J McDougle
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

6.  Oxytocin enhances brain function in children with autism.

Authors:  Ilanit Gordon; Brent C Vander Wyk; Randi H Bennett; Cara Cordeaux; Molly V Lucas; Jeffrey A Eilbott; Orna Zagoory-Sharon; James F Leckman; Ruth Feldman; Kevin A Pelphrey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

7.  Seizure disorders in autism.

Authors:  F R Volkmar; D S Nelson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1990-01       Impact factor: 8.829

Review 8.  Autism spectrum disorders--a genetics review.

Authors:  Judith H Miles
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

9.  The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex.

Authors:  Stephanie M McTighe; Sarah J Neal; Qian Lin; Zoë A Hughes; Daniel G Smith
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study.

Authors:  Padideh Ghaeli; Naemeh Nikvarz; Javad Alaghband-Rad; Abbas Alimadadi; Mehdi Tehrani-Doost
Journal:  Indian J Psychol Med       Date:  2014-01
View more
  47 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

2.  An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.

Authors:  Oakleigh M Folkes; Rita Báldi; Veronika Kondev; David J Marcus; Nolan D Hartley; Brandon D Turner; Jade K Ayers; Jordan J Baechle; Maya P Misra; Megan Altemus; Carrie A Grueter; Brad A Grueter; Sachin Patel
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

3.  Rigor and reproducibility in rodent behavioral research.

Authors:  Maria Gulinello; Heather A Mitchell; Qiang Chang; W Timothy O'Brien; Zhaolan Zhou; Ted Abel; Li Wang; Joshua G Corbin; Surabi Veeraragavan; Rodney C Samaco; Nick A Andrews; Michela Fagiolini; Toby B Cole; Thomas M Burbacher; Jacqueline N Crawley
Journal:  Neurobiol Learn Mem       Date:  2018-01-04       Impact factor: 2.877

Review 4.  Behavioral and neuroanatomical approaches in models of neurodevelopmental disorders: opportunities for translation.

Authors:  Jill L Silverman; Jacob Ellegood
Journal:  Curr Opin Neurol       Date:  2018-04       Impact factor: 5.710

Review 5.  Autistic traits in epilepsy models: Why, when and how?

Authors:  Jana Velíšková; Jill L Silverman; Melissa Benson; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Res       Date:  2018-05-18       Impact factor: 3.045

6.  Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.

Authors:  P T Leach; J N Crawley
Journal:  Genes Brain Behav       Date:  2018-02-15       Impact factor: 3.449

Review 7.  Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.

Authors:  Aileen Rivell; Mark P Mattson
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

Review 8.  Resolving the Synaptic versus Developmental Dichotomy of Autism Risk Genes.

Authors:  Whitney E Heavner; Stephen E P Smith
Journal:  Trends Neurosci       Date:  2020-02-22       Impact factor: 13.837

9.  Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.

Authors:  Nycole A Copping; Sarah G B Christian; Dylan J Ritter; M Saharul Islam; Nathalie Buscher; Dorota Zolkowska; Michael C Pride; Elizabeth L Berg; Janine M LaSalle; Jacob Ellegood; Jason P Lerch; Lawrence T Reiter; Jill L Silverman; Scott V Dindot
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

10.  Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.

Authors:  Jessica L Nuwer; Megan L Brady; Nadya V Povysheva; Amanda Coyne; Tija C Jacob
Journal:  Neuropharmacology       Date:  2021-07-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.